Detalhe da pesquisa
1.
Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin+ foam cell differentiation in the prostate.
J Pathol
; 260(2): 177-189, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825524
2.
Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Proc Natl Acad Sci U S A
; 115(47): 12028-12033, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373845
3.
Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.
Int J Mol Sci
; 22(22)2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830342
4.
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression.
Prostate
; 80(13): 1058-1070, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692871
5.
Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Prostate
; 80(10): 731-741, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356572
6.
Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
Proc Natl Acad Sci U S A
; 114(6): 1359-1364, 2017 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28123062
7.
Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
Prostate
; 78(13): 970-980, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29786867
8.
A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
Br J Haematol
; 181(4): 476-485, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663325
9.
Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.
Proc Natl Acad Sci U S A
; 112(44): 13651-6, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474831
10.
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
Proc Natl Acad Sci U S A
; 111(2): 781-6, 2014 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379381
11.
Phospholipase C-η2 interacts with nuclear and cytoplasmic LIMK-1 during retinoic acid-stimulated neurite growth.
Histochem Cell Biol
; 145(2): 163-73, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26671787
12.
Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation.
Proc Natl Acad Sci U S A
; 110(36): 14801-6, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959899
13.
A canonical EF-loop directs Ca(2+) -sensitivity in phospholipase C-η2.
J Cell Biochem
; 115(3): 557-65, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123053
14.
PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE.
bioRxiv
; 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712029
15.
Phospholipase C-η2 is required for retinoic acid-stimulated neurite growth.
J Neurochem
; 124(5): 632-44, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23237262
16.
The Multifaceted Role of Osteopontin in Prostate Pathologies.
Biomedicines
; 11(11)2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001899
17.
Putative roles for phospholipase Cη enzymes in neuronal Ca2+ signal modulation.
Biochem Soc Trans
; 40(1): 282-6, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22260706
18.
GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.
Cell Mol Life Sci
; 68(1): 85-95, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812023
19.
Current research and future directions in non-malignant urologic research - proceedings of the annual CAIRIBU meeting.
Am J Clin Exp Urol
; 10(6): 449-461, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36636691
20.
Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
Peptides
; 150: 170716, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952135